The pharmaceutical world is witnessing a remarkable shift in glucose therapy with the emergence of GLP-1 patches. These patches offer a possibly more comfortable alternative to shots of GLP-1 receptor agonists, minimizing the frequency of daily needle pricks. The technology delivers the drug directly through the epidermis, possibly enhancing per… Read More